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6SUMMARY
The production and use of industrial enzymes have increased markedly
during the last few decades. Today, enzymes are used, for example,
in the detergent, food, feed, textile and pulp and paper industries.
Respiratory allergies to powdered microbial enzymes surfaced in the
late 1960s in the detergent industry. With improvements in industrial
hygiene, the problem abated. Since the 1980s, allergies have emerged
in other industries however, notably in bakeries.
A series of studies on enzyme allergy was performed in 1992–1997.
The aim was to assess exposure and allergy to enzymes in Finnish
enzyme manufacturing and industries using enzymes. Investigations
were performed in four bakeries, one flour mill, one rye crisp factory,
one detergent factory, four animal feed factories, one biotechnical
research laboratory and one biotechnical plant having both research
and production units.
For determining α-amylase, a catalytic method was used which
detects also the inherent amylase of flour. For protease detection both
a catalytic method and a more specific immunologic procedure were
used. Cellulase and xylanase were measured with an immunologic
method.
Powdered enzyme-containing additives were used in the bakeries,
where high α-amylase levels, up to 6.6 µg/m3, were found during
dough making. In other locations, the levels were generally lower,
below 0.2 µg/m3. In addition, xylanase concentrations of 2–
200 ng/m3 (mean 65 ng/m3) were found, possibly also due to inherent
xylanase. Enzyme-containing additives were mixed in the four
mill, and α-amylase concentrations up to 1.1 µg/m3 and cellulase
concentrations up to 180 ng/m3 were determined at the mixing sites.
In the rye crisp factory the α-amylase levels were lower than in
the bakeries (mean value 0.1 µg/m3 for personal samples and
0.03 µg/m3 for stationary samples). The cellulase concentrations
ranged from 25 to 160 ng/m3 in different phases of the mixing, dough
making and bread forming. At the same sites, lower levels (7–
40 ng/m3) of xylanase were measured.
In the animal feed factories, the nonspecific assay showed high
levels of protease (up to 0.4–2.9 µg/m3) and α-amylase (up to
0.2 µg/m3), which coincided with the high total dust levels but not
with the amount of added enzyme.
In the detergent factory, the protease levels, measured with a
catalytic method, were generally below 50 ng/m3, but at the enzyme
mixing site very high concentrations, above 1000 ng/m3, were found.
The analysis with an immunologic method gave results of the same
7order, indicating that the main origin of the protease was the added
enzyme.
Few measurements prior this study from the enzyme manufacturing
industry had indicated cellulase concentrations on the order of
50 ng/m3 in laboratory work. Judging from job descriptions, much
higher enzyme concentrations probably occurred occasionally during
the mixing, drying and packing of enzymes.
The prevalence of sensitization to enzymes, assessed by skin prick
testing, was 7.8% in the bakeries, 4.8% in the flour mill and 2.7% in
the rye crisp factory. When the office personnel was excluded, the
figures were 8.4%, 5.3% and 3%, respectively. In the animal feed
industry the corresponding prevalences were 4.6% and 7.1%, and in
the detergent industry 11.8% and 22.5%. In the biotechnical research
laboratory 11.7% of the workers and in the biotechnical plant 12.6%
of the workers were sensitized. In the category of research, laboratory
and enzyme manufacturing work, the rates were 12.6% and 15.4%,
respectively. A statistically significant exposure-response linear trend
was demonstrated among the biotechnical workers. Atopy, as
demonstrated using skin prick testing, increased the risk of
sensitization three to five times among the workers studied, except
in the detergent factory.
Sensitization to enzymes was associated with work-related
respiratory symptoms in all the industries studied. Several cases of
specific occupational asthma or rhinitis due to enzymes were
diagnosed later, thus verifying the causal connection of sensitization
to clinical allergy. The bronchial challenge method used proved to
be practical for challenges with powdered enzymes.
Sensitization was found for previously well-known enzymes, such
as protease in the detergent industry and α-amylase in the bakeries.
Lipase and cellulase were also shown to be allergens in the detergent
industry. In addition, it was found that phytase causes sensitization
in enzyme production and the animal feed industry. Sensitization
to cellulase and xylanase was common due to the increasing
manufacture of these enzymes in Finland. Immunoblotting showed
that the antigens of α-amylases of bacterial and fungal origin differed
from each other, as the sera from persons sensitized to fungal amylase
did not bind to bacterial amylase, and vice versa.
Development and international standardization are urgently
needed to establish methods for measuring air concentrations
of enzymes. For the prevention of sensitization to enzymes and
allergic diseases caused by them, the risk of allergy has to be
recognized at workplaces, and exposure to enzymes must be kept
to a minimum.
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ELISA enzyme-linked immunosorbent assay
FIOH Finnish Institute of Occupational Health
FEV1.0 forced expiratory volume in 1 second
IgE immunoglobulin E
kDa kilo Dalton
MW molecular weight
OA occupational asthma
OEL occupational exposure limit
PEFR peak expiratory flow rate
py person-year
RAST radioallergosorbent test
TLV threshold limit value
SPT skin prick test
wt/vol weight/volume
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1. INTRODUCTION
Enzymes are proteins that are present in all cells and that catalyze
chemical reactions. Along with the progress of modern biotechnology
during the past 20 years, the production and use of industrial enzymes
have multiplied. For example, by breaking down protein, carbohydrate
and lipid molecules in stains, enzymes enhance the action of
detergents. The baking process is improved by different enzyme
actions on the dough, and the stone washing effect of jeans is
achieved by cellulotic enzyme action on the fabric.
The allergenic potency of enzymes was confronted in the enzyme
production and detergent industries worldwide in the late 1960s. The
health effects were primarily respiratory allergies (asthma, rhinitis).
As a consequence of allergies in the detergent industry, major
industrial hygiene improvements were made, such as encapsulation
of the enzyme product and other means of decreasing exposures. As
a result, there has been a great reduction in the occurrence of allergies
in the detergent industry since the mid-1970s. However, when
enzymes were introduced gradually to other industries, allergies
emerged in, for example, the pharmaceutical and baking industries
in the 1980s.
In Finland, the experience with enzyme-induced allergies started
to grow in the beginning of the 1990s when allergies emerged in the
expanding enzyme manufacturing industry. A research project was
started at the Finnish Institute of Occupational Health (FIOH) with
the aim of gathering data on the use of enzymes in Finland and
assessing exposure, sensitization and allergic symptoms due to
enzymes.
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2. REVIEW OF THE LITERATURE
2.1. What enzymes are
Enzymes are proteins that are present in all living cells, where they
perform a vital function by controlling the metabolic processes
whereby nutrients are converted into energy and fresh cell material.
Enzymes perform these tasks as catalysts; in other words, they speed
up the chemical processes, without being consumed in the
process (Stryer 1999). A unique feature of enzymes is also their great
specificity (i.e., each enzyme can break down or synthesize one
particular compound or work on a specific bond only). Enzymes are
also very efficient, one enzyme molecule being able to catalyze the
breakdown of millions of molecules. These features are utilized in
industrial processes. Furthermore, being proteins, they are readily
degradable and, as such, are ideal for the environment. Being formed
to work in living cells, enzymes can work at atmospheric pressure
and under mild conditions in terms of temperature and acidity (pH).
Most enzymes function optimally at a temperature of 30–70°C and
at pH values that are near neutral (pH 7).
2.2. History of enzyme use and technology
Enzymes have been used by humans throughout the ages, either
in the form of vegetables rich in enzymes or in the form of
microorganisms used for a variety of purposes, for instance, brewing
processes, baking, cheese manufacturing and the production of
alcohol. In 1876, William Kühne proposed the term “enzyme”, which
means “in yeast” and is derived from the Greek words “en” and
“zyme” (Voet & Voet 1995). Development in protein chemistry
methods in the 19th century, and in the beginning of the 20th
century, led to the extraction and production of enzymes from animal
and plant tissue, such as rennet from calves’ stomachs (for cheese
production) and pancreatic extracts for bating in leather
manufacturing and for use in detergents (Gerhartz 1990).
The development of the submerged-culture technique represented
a major advance in enzyme technology since it permitted the large-
scale production of microorganisms for industrial purposes. Such a
technique was introduced early in the 1950s at a time when the
production of bacterial amylases was begun for the textile industry
by a Danish company. Very soon other microbial enzymes were also
produced. In 1959, the first detergent containing a bacterial protease
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was introduced. The manufacture of enzymes for industrial purposes
progressed rapidly after 1965, due mainly to the increasing use of
enzymes in detergents.
2.3. Modern production of enzymes by
microbes
Initial laboratory work includes the selection and modification of
microorganisms so that they are capable of producing the desired
enzymes at high yields (Gerhartz 1990). The selected strains are
combined with specially selected sterile nutrient media in a “seed
tank”, where the biological amplification occurs. Once sufficient mass
has accumulated, the culture is aseptically transferred to a large
fermentation tank. During the ensuing fermentation, enzyme
production occurs. Enzymes are then separated from the biomass
through a series of filtration steps. The enzyme slurry is pumped to
the filter system where a major portion of the suspended solids is
separated from the enzyme liquid. The enzyme liquid is concentrated
with an evaporator and refiltered to remove unwanted bacterial
contamination. Following filtration, enzyme activity is stabilized, and
preservative materials are added to the product. The final commercial
product is either in liquid, powder or granulated (encapsulated) form.
The latter two forms are produced using spray-drying procedures.
Usually the commercial enzyme product does not need to be
“pure” in order to perform the task for which it is intended. Thus it
may contain other enzyme activities produced by the microorganism,
and other proteins or parts of proteins from the media as well.
Currently, the most common microbes used in the production
of enzymes are the molds Aspergillus oryzae, A.niger and
Trichoderma reesei and the bacteria Bacillus subtilis and Bacillus
amyloliquefaciens. With the tools of genetic engineering, the
primary gene coding the enzyme may come from a separate
microbe (or from, e.g., any mammalian cell) rather than from the host
microbe.
2.4. Classification of enzymes
According to the reactions they catalyze, enzymes can be classified
into oxidoreductases, transferases, hydrolases, lyases, isomerases and
ligases (Stryer 1999). In industrial use, by far the most important
group is the hydrolases. Hydrolases cleave certain bondages
of molecules hydrolytically. They are separated and named
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according to the substances they cleave (e.g., amylases, cellulases,
hemicellulases, proteases, pectinases, lipases and lactases).
2.5. Applications of industrial enzymes
The detergent and food industries are the most important users of
enzymes (Gerhartz 1990, AMFEP 2001). However, their application
is increasing, for example, in the textile and animal feed industries.
In the detergent industry the most common enzymes are Bacillus-
derived proteases. Several different proteases are available, with
differences, for example, in the pH and temperature range in which
they function. Other enzymes, such as α-amylases, lipases, and
cellulases, have been introduced later. In addition to the traditional
use of enzymes in laundry detergents, enzymes have recently been
incorporated into dishwashing detergents. The detergent is usually
less than 1% enzymes. Since the early 1970s the detergent enzymes
have been granulated or encapsulated products. The role of enzymes
is to break down protein, lipid and carbohydrate molecules of stains
in fabrics. Enzymes are used also in personal care products, for
example, in contact lense cleansing solutions and toothpastes.
In bakeries enzymes have been used increasingly since the early
1980s; now most (80–90%) Finnish bakeries use enzyme-containing
additives, also called “bread improvers”. The enzyme usually
comprises only 0.2–1% of the total weight of the additive. The amount
of the additive in the dough is about 1%. α-Amylase of fungal
origin (A. oryzae) is by far the most common enzyme; others
are α-amylase of bacterial origin, glucoamylase, xylanase, lipase and
glucose oxidase. Although liquid and paste forms have been available
for several years, powdered products are still the most commonly
used. The benefits of enzymes in baking are the improved dough
handling properties, the increased bread volume, the improved
crumb structure and the retarded staling process (Poutanen 1997).
α-Amylase is used to speed up the degradation of starch in the
production of sugar. Glucose isomerase converts glucose into
fructose and is utilized in the production of “high fructose syrup”,
used in sweetening of foodstuffs.
In the alcohol and brewing industries, enzymes are used to break
down starch into smaller molecules that the yeast can transform into
alcohol. Traditionally, enzymes have been provided by adding malt.
Because of their effectiveness, standardized activity and easier
handling, modern enzymes have largely replaced malt. Enzymes
improve also the filtering process. α-Amylase, glucoamylase,
cellulololytic enzymes and proteases are used. Cellulases and
15
pectinases are also used to in the production of fruit juice.
Applications of enzyme use have been developed even for
winemaking.
In cheese manufacturing, the traditional enzyme, calf rennet, is
being replaced by microbial chymosin. Lactase is used to cleavage
lactose in dairy products. Other applications of enzymes in food
industry are being developed, e.g. in vegetable oil production and
the food functionality industry.
In pharmaceutical industry, several enzymes are used as
constituents of medicines (e.g. digestive aids) or as preservatives.
When included in animal feed, enzymes improve the digestion
of the feed, especially in monogastric animals such as poultry and
pigs. The enzymes break down digestible proteins and starch from
the feed fibers. In addition, enzymes can be used to increase the
availability of minerals, especially phosphorus, from the feed. Better
degradation of feed also makes the excrements more solid.
Consequently, enzymes are marketed also as having a favorable
environmental impact.
Applications of enzymes in the textile industry are expanding
rapidly. For example, denim is given the “stone-washing” effect, and
the fuzz can be removed from clothes by the action of cellulase
(Tenkanen et al 1999).
In the pulp and paper industry, xylanases are used to help bleach
the pulp and thus decrease the need for chlorine compounds.
Cellulase can be used for the de-inking of waste paper, and lipases
are used to reduce pitch deposits in paper mills (Viikari et al 1998).
In the leather industry, extra proteins and fats can be removed
from the hides by using microbial proteases and lipases, in addition
to the traditional pancreatic protease.
The most common enzymes used in different industries and the
estimated number of exposed employees in Finland are listed in
Table 1.
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2.6. Health effects of industrial enzymes
2.6.1. Respiratory allergies caused by enzymes
Reviews on allergies from enzymes have also been published recently
(Brisman 1994, Houba et al 1998a, Bernstein 1999a).
Studies on respiratory allergies caused by enzymes are summarized
in Tables 2–4 according to industry.
2.6.1.1. Detergent industry
A marked enzyme allergy problem appeared in the late 1960s and
early 1970s, when clusters of enzyme allergy emerged rapidly in
enzyme production and the detergent industries. The appearence was
linked to the expanded production of B. subtilis proteases. The first
report was published by Flindt (1969), who described asthmatic
symptoms emerging in a detergent factory during the course of the
first year that proteases were introduced in the plant. Out of a group
of symptomatic workers, 25 had positive skin prick tests (SPTs)
to one or two protease products (Alcalase®, Maxatase®). After this
report, epidemiological studies started to accumulate from the
industry. The sensitization rate was 5–50%, and 5–30% had work-
related symptoms (Wüthrich & Ott 1969, Greenberg et al 1970,
McMurrain 1970, Newhouse et al 1970, Shapiro et al 1971, Weill et
al 1971, Göthe et al 1972, Gilson et al 1976, Belin & Norman 1977,
Juniper et al 1977, Zachariae 1981, Juniper & Roberts 1984, Pepys
et al 1985, Flood et al 1985). The symptoms were primarily
respiratory (asthma, rhinitis), and only a few skin symptoms were
reported, whose origin was considered to be irritation, not
sensitization.
After the initial reports of high allergy prevalences in the industry,
the rapid growth of enzyme detergents was temporarily set back in
the early 1970s. Vigorous actions were taken to solve the problem,
including the development of encapsulated enzyme products (to
prevent dusting) and improvements in industrial hygiene at the
worksites, such as enclosure of processes and use of respiratory
protective equipment. Some of the factories ceased using enzymes.
Some adopted the practice of excluding atopics from enzyme work
(Newhouse et al 1970, Witmeur et al 1973, Juniper et al 1977).
A major reduction in sensitization and symptoms was reported among
employees (Gilson et al 1976, Juniper et al 1977, Juniper & Roberts
1984, Pepys et al 1985, Flood et al 1985). The enzyme allergy problem
in the detergent industry seemed to have abated. Large multinational
companies reported a yearly incidence of 2–3% new cases of
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sensitization and a prevalence of up to 10% but few or no cases of
asthma during the 1990s (Gaines 1994, Cathcart et al 1997, Sarlo
et al 1997a, Schweigert et al 2000). Recently, however, a high
prevalence of sensitization to enzymes (26%) and a prevalence of
16% for work-related lower-respiratory symptoms accompanied with
sensitization were reported in a detergent factory in the United
Kingdom (Cullinan et al 2000).
In Finland, little data exist on allergies in the detergent industry.
A case report described two employees, a processman and a packer,
who probably had enzyme-induced asthma. Their symptoms started
in 1967, about one year after the introduction of enzymes in the
factory, and sentitization to the protease used was proved by scratch
tests in 1969 (Stubb 1972).
2.6.1.2. Pharmaceutical industry, health care and
related occupations
Several case reports and surveys in small populations of, for example,
food technologists and pharmaceutical workers with respiratory
symptoms and sensitization to plant-derived papain were published
in the 1970s and 1980s (Milne & Brand 1975, Flindt 1978, Flindt 1979,
Baur & Fruhmann 1979a, Baur et al 1982, Novey et al 1980). Allergies
due to chymotrypsin and trypsin were reported by Howe et al (1961)
and Zweiman et al (1967), and due to pancreatic extracts by
Wiessmann and Baur (1985) and by Hayes and Newman Taylor
(1991). Asthma due to pepsin in pharmaceutical employees was
described by Maisel (1940) and Cartier et al (1984) and to pectinase
by Hartmann et al (1983). Galleguillos and Rodriquez (1978) and Baur
and Fruhmann (1979b) reported asthma due to bromelain. In the
1990s, high prevalences of sensitization to α-amylase and lactase were
reported in the pharmaceutical industry (Losada et al 1992, Muir et
al 1997, Bernstein et al 1999b). A detergent protease, subtilisin,
caused asthma in a hospital worker who cleaned instruments
(Lemiere 1996). The first report of cellulase as an occupational
allergen was that by Ransom and Schuster (1981): the enzyme caused
astma in a laboratory worker during plant cloning experiments.
In Finland, papain caused sensitization and rhinitis or asthma in
three laboratory employees in a laboratory that used papain as a
substrate in vaccine production in 1984 and in one laboratory
employee in 1994 (Finnish Register of Occupational Diseases). A case
of papain allergy in a cosmetologist was reported in 1993 (Niinimäki
et al 1993).
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2.6.1.3. Baking industry
The first report of Aspergillus-derived α-amylase allergy was
published by Flindt in 1979, when five out of eight symptomatic
employees in an enzyme-handling factory were sensitized to
α-amylase. In the mid-1980s, reports from allergies induced by
exposure to α-amylase in the baking industry started to appear. Baur
et al (1986) reported sensitization, in a radioallergosorbent test
(RAST), to α-amylase in 34% of 27 symptomatic bakery workers in
Germany. In a subsequent paper, Baur et al (1988) reported a
sensitization rate (by RAST) of 24% for α-amylase, 8% for
hemicellulase or cellulase, and 5% for amyloglucosidase. In Sweden,
Brisman and Belin (1991) published a report on four symptomatic
workers in a factory where amylase-contained baking additives were
prepared. In Spain, Quirce et al (1992) described five symptomatic
bakers. In Italy, 17 (7.5%) of 226 bakers and pastry makers were
sensitized to enzymes (De Zotti et al 1994). In the United Kingdom,
5% of 344 subjects were sensitized in bakery or flour mill work
(Cullinan et al 1994), and up to 16% sensitization was reported in a
selected plant bakery population (Smith et al 1997). In The
Netherlands, 9% of 178 bakery workers were sensitized to α-amylase
(Houba et al 1996). A German study comprising a retrospective
analysis of sera from 171 symptomatic bakers revealed a sensitization
rate of 23% for α-amylase, 8% for amyloglucosidase, 13% for cellulase
and 11% for xylanase (Sander et al 1998). In Scotland, 15% of
205 bakery employees were found to be sensitized to α-amylase
by RAST (Jeffrey et al 1999). In the United Kingdom, 5% of
264 employees were sensitized to amylase (Nieuwenhuijsen et al
1999).
Few longitudinal studies have been published on the incidence
of enzyme allergy in the baking industry. In a cohort of Italian trainee
bakers, 125 subjects were tested at 6, 18 and 30 months after the
baseline examination. At the baseline, 4 were sensitized to flour or
α-amylase; at 30 months, the corresponding number was 10 sensitized
to flours, 3 of whom also showed sensitization to amylase (De Zotti
& Bovenzi 2000). In the United Kingdom, a nested case-control
analysis of a cohort of new bakers was reported recently (Cullinan
et al 2001). Out of 300 bakers, 21 had developed sensitization to flour,
2.2. cases per 100 person-years (py), and 24 to α-amylase, 2.5 cases
per 100 py.
A correlation between α-amylase and flour sensitization was found
in studies in which both substances were assessed. For example, the
amylase/flour sensitization prevalences were 5%/5% (Cullinan et al
1994), 7.5%/11.9% (De Zotti et al 1994), 9%/8% (Houba et al 1996),
19%/16% (Baur et al 1998a); 16%/6% (Smith & Smith 1998), and 15%/
20
24% (Jeffrey et al 1999). Co-sensitization (amylase and flour) was
common.
The reported work-related respiratory symptoms in bakeries have
a wide range: from a prevalence of 0.5% for asthmatic symptoms and
2.6% for rhinitis (Smith & Smith 1998) to 33% for rhinitis and dyspnea
(Baur et al 1998a). A high prevalence of asthmatic symptoms (20.9%)
was reported in small bakeries in Scotland (Jeffrey et al 1999). In a
United Kingdom cohort of new bakers, the incidence was 11.8/100
py for work-related eye or nose symptoms and 4.1/100 py for chest
symptoms (Cullinan et al 2001). The incidence of work-related chest
symptoms in the presence of a positive SPT to flour or amylase was
1/100 py.
In Finland, only a few bakery workers, out of a total of about 9000
people per year working in the industry, have been diagnosed as
having occupational disease as a result of exposure to enzymes. In
1990–1999, altogether 263 cases of occupational asthma due to flour
exposure and only 3 due to amylase exposure were reported, as were
278 cases of rhinitis due to flour exposure, and 3 cases due to amylase
exposure (Finnish Register of Occupational Diseases). The following
reasons have been proposed: (1) flour-induced allergy is primarily
searched for and diagnosed, leaving simultaneous enzyme allergy
unrecorded, and (2) workers and health professionals are often
unaware of the use of enzymes in the workplace.
2.6.1.4. Enzyme-producing industry
A Danish company, the largest enzyme manufacturer in the 1960s–
1980s, reported sensitization prevalences (by RAST) of 3.3 and 10%
for detergent proteases during the 1970s (Witmeur et al 1973,
Zachariae et al 1981); 3% and 8.5% respectively, experienced
respiratory symptoms in conjunction with enzyme exposure. The
company published data from its medical surveillance program of
employees again in 1997 (Johnsen et al 1997). During the period
1970–1992, 8.8% of the employees developed clinical enzyme allergy
during the first 3 years of employment. The frequency was 5.3% for
asthma, 3.0% for rhinitis and 0.6% for urticaria. Several enzymes, like
amylases, cellulases and lipase, appeared as allergens.
In Finland enzyme production expanded rapidly during the 1980s
and 1990s, and the first five cases of enzyme allergy due to
Trichoderma-derived cellulase and xylanase were reported in 1991
(Tarvainen et al 1991). Thus far, 35 cases of occupational disease due
to enzyme exposure in enzyme production have been diagnosed,
out of a total workforce of about 500–600 during 1990–2000 (Finnish
Register of Occupational Diseases). By far the most common
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causative enzyme has been cellulase (27 cases); others have been
xylanase, phytase, α-amylase, glucoamylase, protease and pectinase.
Occupational asthma was diagnosed in 22, rhinitis (without asthma)
in 9, contact urticaria in 10, and conjunctivitis in 2 cases.
2.6.1.5. Other industries
Few reports exist from food industry except the bakeries. In Finland,
a cheesemaker was sensitized to powdered microbial rennet and had
dyspnea in conjuction with exposure (Niinimäki & Saari 1978).
Recently, pectinace and glucanase, used in the preparation of citrus
fruits for fruit salads, were reported to cause sensitization and asthma
(Sen et al 1998). The first case report of cellulase allergy in the textile
industry was published by Kim et al (1999). In Finland, a case of
occupational asthma due to cellulase in jeans finishing was diagnosed
in 2000 (Finnish Register of Occupational Diseases). Phytase, taken
into use recently, was reported to cause sensitization in 8 of 11
exposed workers in the animal feed industry (Doekes et al 1999) and
asthma in one worker in an animal feed factory (O’Connor et al 2001).
2.6.2. Dermatitis due to enzymes
A recent review presents dermatological symptoms induced by
exposure to enzymes (Kanerva & Vanhanen 2000). In the detergent
industry, irritant dermatitis was common in the late 1960s, but allergic
findings were rare (McMurrain 1970, Göthe et al 1972, Zachariae et
al 1973). Case reports have been published of urticaria and protein
contact dermatitis due to exposure to α-amylase in bakeries (Schirmer
et al 1987, Morren et al 1993) and due to exposure to α-amylase,
cellulase and xylanase in the enzyme manufacturing industry
(Tarvainen et al 1991, Kanerva et al 1997, Kanerva et al 1998, Kanerva
& Vanhanen 1999). In most of these cases, the sensitization was
proved with SPTs. Few of the cases showed positivity for both the
SPT and the patch test (Schirmer et al 1987, Morren et al 1993,
Tarvainen et al 1991).
2.6.3. Allergy to enzymes among consumers
Enzyme-containing pancreatic extracts, used as a medication for
patients with cystic fibrosis, were reported to cause sensitization and
asthma in the parents of children with cystic fibrosis (Dolan & Meyers
1974, Sakula et al 1977), and also in a dog owner who gave the drug
to the pet (Warren & Dolovich 1986).
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Allergies in the detergent industry coincided with the emergence
of allergies in consumers of detergents (Belin et al 1970, Bernstein
1972, Zetterström & Wide 1974). With the decrease of enzyme
addition in the formulations and the use of encapsulated preparations,
the allergies ceased (Pepys et al 1973, White et al 1985, Sarlo et al
1996). Contact urticaria has been reported as a result of exposure to
papain in cleansing solutions for contact lenses (Bernstein et al 1984,
Santucci et al 1985). Recently a detergent company published an
experiment in which volunteers used a shower gel that contained
protease enzyme. Because of the detection of protease in the shower
aerosol and the appearance of sensitization to protease in the test
persons, the company decided not to add enzymes to its shower gel
products (Kelling et al 1998).
A case report report described a severe systemic allergic reaction
after ingesting meat tenderizer that contained the proteolytic enzyme
papain (Mansfield & Bowers 1983). Allergy to α-amylase in bread has
been suggested in two case reports showing that eating bread
baked with the aid of amylase caused allergic symptoms in two
previously occupationally (by inhalation) sensitized individuals
(Kanny & Moneret-Vautrin 1995, Baur & Czuppon 1995). It was also
demonstrated that bread contained residual amounts of antibody-
binding α-amylase that was not destroyed by the baking process (Baur
et al 1996, Sander et al 2000).
2.6.4. Determinants of sensitization
Exposure-response relationships in the detergent industry were first
assessed by Weill et al (1971). The risk of sensitization increased along
with the exposure in three groups of workers, the groups being
formed according to estimated (work task) and monitored exposure
to enzymes. In bakeries, Houba et al (1996) showed a strong positive
association between measured α-amylase exposure levels and amylase
sensitization. α-Amylase exposure levels above 0.25 ng/m3 as an
average exposure during an 8-hour work shift increased the risk of
sensitization of bakery workers. In another bakery study, a significant
exposure-response relationship was noted between exposure and
sensitization in three exposure groups (< 5 ng/m3, 5–15 ng/m3 and
>15 ng/m3) (Nieuwenhuijsen et al 1999).
Atopy has been shown to be a strong determinant of sensitization
to enzymes in most studies, atopics (determined usually by SPT) being
up to 4–5 times more prone to sensitization (Brisman 1994, Bernstein
et al 1999a). Smoking, on the other hand, has been shown to be
a risk factor only occasionally (De Zotti et al 1994, Johnsen et al
1997).
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2.7. Characterization of enzyme allergens
The most thoroughly analyzed industrial enzyme is α-amylase derived
from A.oryzae. Several proteins that bind to immunoglobulin E (IgE)
have been detected in crude enzyme preparations, the dominating
band having a molecular weight (MW) from 51 to 54 kDa (Quirce et
al 1992, Baur et al 1994, Sandiford et al 1994, Houba et al 1997). The
allergens were further studied, purified and identified (Baur et al
1994). A protein with a MW of 53 kDa was shown to represent the
dominating allergen. The enzyme is a 478 amino-acid glycoprotein.
The allergen was named Asp o 2. A xylanase from A. niger, used in
baking additives, was shown to be allergenic, the allergen being
β-xylosidase of 105 kD (Sander et al 1998).
Kim et al (1999) demonstrated that a cellulase preparation derived
from T.viride and Fusarium moniliform had at least eight IgE binding
components, the strongest band being at 56–63 kDa.
The structure of an increasing number of environmental allergens
has been determined (Aalberse 2000, Liebers et al 1996). Many of
the allergens are functionally enzymes, for example, the allergens of
flour, house dust mite and molds (Liebers et al 1996, Tiikkainen et al
1996, Houba et al 1998a, Sander et al 2001, Robinson et al 1997, Lake
et al 1991, Robinson et al 1990). The proteolytic function of many
of these allergens has been proposed to be an important factor in
the epithelial permeability and origin of allergy (Robinson et al 1997,
Kauffman et al 2000). Sandiford et al (1994) showed cereal amylases
to be important allergens in patients with allergy to flour, but only
minimal cross-reactivity was found between cereal amylases and
fungal a-amylase.
2.8. Diagnosing enzyme-induced asthma with a
challenge test
Enzymes cause the following clinical symptoms and diseases typical
of type I hypersensitivity: asthma, rhinitis, conjunctivitis, and
urticarial skin symptoms. Guidelines have been introduced for the
diagnostics of occupational asthma (Subcommittee on Occupational
Asthma of the EAACI 1992). The recommended five steps
were as follows: (1) history suggestive of occupational asthma,
(2) confirmation of asthma, (3) confirmation of work-related
bronchoconstriction with serial measurements of peak expiratory
flow rate (PEFR) and confirmation of non-specific bronchial reactivity,
(4) confirmation of sensitization to occupational agents, and
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(5) confirmation of the causal role of the occupational agent with
specific bronchial challenges.
The bronchial challenge test is regarded as the gold standard in
the diagnosis of occupational asthma (Pepys & Hutchcroft 1975,
Nordman 1994a, Chan-Yeung & Malo 1995, Cartier 1998, Cartier &
Malo 1999). It is superior to PEFR in specificity and preferred
especially when there is uncertainty about the causative agent or the
agent is a “new” sensitizer or the patient history indicates severe
symptoms, and uncontrolled PEFR monitoring is not regarded as
being as safe as a controlled challenge test.
Challenge tests with enzymes have been performed with a variety
of protocols (Table 5). Basically, there are two different methods.
One is to generate an aerosol or dust and inhale it through a special
device. Another is a protocol in which the substance to be inhaled
is generated into the free space (in a challenge chamber), where the
subject inhales the dust.
2.9. Monitoring of enzymes in
the workplace air
Since the late 1960s, methods to determine airborne enzymes have
been in use, first in the production of proteases and in the use of
proteases in the detergent industry and, since the late 1980s, in
bakeries. Proteases have been measured with catalytic methods in
detergent factories (Newhouse et al 1970, Weill et al 1971, Juniper
et al 1977, Bruce et al 1978, Liss et al 1984) and, gradually, with
immunologic methods (Agarwall et al 1986, Gaines 1994, Cathcart
et al 1997, Kelling et al 1998). In the baking industry α-amylase has
been measured with catalytic methods (Brisman & Belin 1991,
Jauhiainen et al 1993) and later with immunologic methods (Houba
et al 1996, Sander et al 1997, Burstyn et al 1998, Nieuwenhuijsen et
al 1999, Elms et al 2001).
2.9.1. Catalytic methods
The catalytic methods for measuring enzymes are based on the
specific enzymatic function of the enzyme in question; accordingly,
only active enzyme is measured. Air samples are filtrated through
glassfiber filters using high-volume samplers, followed by the analysis
of filter eluates for their ability to hydrolyze the substrate (Dunn &
Brotherton 1971, Rothgeb et al 1988, Jauhiainen et al 1993). Assays
have also been developed for real-time monitoring of some protease
enzymes in workplace air (Tang et al 1996).
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2.9.2. Immunologic methods
Immunologic methods are based on enzyme-specific antibodies.
Agarwall et al (1986) were the first to report an immunologic method
for quantitating a protease (Esperase®) in the detergent industry. The
method used a two-site immunoradiometric assay and had a
great sensitivity (1 ng/m3). Another method utilizes enzyme-linked
immunosorbent assay (ELISA) in the immunodetection of detergent
protease and cellulase (Miller et al 1990, Miller et al 1994, Kelling et
al 1998). The detection limit was as low as 0.2–0.5 ng/m3.
Immunochemical methods for α-amylase in bakeries have been
reported since 1996. Houba et al (1996) developed a method in which
the enzyme is detected using sandwich enzyme immunoassay (EIA).
Polyclonal anti-amylase antibodies were used. The detection limit for
amylase allergen measurement in personal sampling was as low as
0.25 ng/m3. This method was used in measurements in bakeries in
The Netherlands (Houba et al 1996, 1997), the United Kingdom
(Nieuwenhuijsen et al 1999) and Canada (Burstyn et al 1998). In
Germany, a two-site monoclonal antibody ELISA was developed to
quantify the allergen Asp o 2 (α-amylase from A.oryzae). The assay
used two monoclonal antibodies and had a sensitivity of 0.6 ng/ml
(Sander et al 1997). Another method based on monoclonal antibodies
was reported by Elms et al (2001), with a sensitivity of 0.2 ng/ml.
The authors could also monitor short (15 minute) exposures,
detecting short peak exposures that are easily overlooked with longer
sampling times.
A comparison of four immunologic methods for assessing α-
amylase was reported by Lillienberg et al (2000). Three assays used
polyclonal antibodies (Houba et al 1996, Sander et al 2000, Lillienberg
et al 2000) and one employed monoclonal antibodies (Sander et al
1997). The three methods using polyclonal antibodies showed good
agreement, with a factor of less than 2 between the methods for
individual samples. The method with monoclonal antibodies showed
3–6 times higher values for individual samples.
Substantial benefits have been proposed for the immunologic
methods, as compared with the catalytic methods. They detect the
specific enzyme protein in all instances, whether the enzyme is active
or inactive, which is beneficial, as inactivated enzyme proteins (or
parts of proteins) may still act as allergens. Second, the immunologic
assay is more specific. In bakeries, for example, the catalytic method
also measures the activity of inherent cereal amylase. Accordingly,
the assay of Houba et al (1996) appeared to be highly, although not
totally specific for fungal amylase. The assays using monoclonal
antibodies (Sander et al 1997, Elms et al 2001) were even more
specific. Very high concentrations of wheat flour, rye flour, yeast
35
proteins and storage mite allergens did not increase the background
value.
The reported measurements of enzyme levels in industries are
summarized in Tables 6–7. As is apparent from the data, it is often
difficult to compare the concentrations between workplaces due the
different enzymes used, the different monitoring and detecting
methods used, and the different units in use to express the enzyme
activity (in catalytic methods). Detailed data on monitoring results
in the enzyme-producing industry and the detergent industry have
not been published, but it has been reported that a major shift has
occurred from levels of tens or hundreds of micrograms (Weill
et al 1971) to levels under the adopted exposure guideline of
15 ng protein/m3 in the detergent industry (Gaines 1994, Cathcart
et al 1997, Cullinan et al 2000, Schweigert et al 2000). In bakeries,
recent measurements with immunologic methods have revealed
peaks of about 40–300 ng/m3 in dough making, whereas in other
tasks, levels are generally under 10 ng/m3 (Houba et al 1996, Sander
et al 1997, Ståhl et al 1998, Burstyn et al 1998, Nieuwenhuijsen et al
1999, Elms et al 2001).
2.10. Exposure guidelines for enzymes
There is only one threshold limit value (TLV) for industrial enzymes
worldwide: 60 ng of pure chrystalline protein/m3 for subtilisin (a
B.subtilis protease), established by the American Conference of
Governmental Industrial Hygienists (ACGIH 1980). The TLV level was
based on experiences in the detergent industry in the late 1960s and
early 1970s and on some enzyme concentration data. Later, large
detergent companies have adopted occupational exposure guidelines
with a limit of 15 ng protein/m3 (Schweigert et al 2000, Peters et al
2001).
The Soap and Detergent Industry Association (SDIA) (Gilson et al
1976, Schweigert et al 2000) and The Association of Manufacturers
of Fermentation Enzyme Products (AMFEP 1994) have published
guidelines on the safe handling of enzymes for use by their member
companies, as well as for customers.
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3. AIMS OF THE STUDY
The aims of this study were
1 To assess exposure to enzymes in the following three major
enzyme-using industries in Finland: the baking, detergent and
animal feed industries, as well as in the enzyme production and
2 to assess the prevalence of sensitization and work-related
respiratory symptoms to enzymes in these industries.
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4. MATERIAL AND METHODS
4.1. Workplaces and subjects
To investigate exposure and sensitization to enzymes, investigations
were carried out in four bakeries, one flour mill, one rye crisp factory,
one biotechnical research laboratory, one biotechnical plant, one
detergent factory and four animal feed factories. These workplaces
represent major users of enzymes. The selection of industries was
based on international reports of growing numbers of cases of enzyme
allergy, especially in the baking industry, and on the referral of several
symptomatic workers from the Finnish enzyme manufacturing
industry to the Department of Occupational Medicine in FIOH. In
the detergent industry, there had been a paucity of data since the
1970s. The animal feed industry was one of the newest areas to
employ enzymes. Altogether 1132 employees were investigated. All
employees in the workplaces were asked to participate, and the
participation rate was high, well over 90% in all the plants. The
workplaces and employees are summarized in Table 8.
The bakeries were typical small or middle-size Finnish bakeries,
where powdered form enzyme-containing additives were manually
weighed and added to the dough. Local exhaust ventilation was used
during flour pouring in only one bakery, and respiratory protective
devices were seldom worn. The enzyme in the baking additive was
α-amylase, comprising about 0.5% of its total weight. In the flour mill,
mixtures of flour and additives for bakery use were produced;
powdered cellulase, xylanase and α-amylase were used. Exposure
took place mainly in the laboratory. In the rye crisp factory the
enzyme was added automatically to the continuously working dough
machines, in the surroundings of which exposure was possible for
the operators. Mainly cellulase was used. The cellulase content
of the dough was less than one-tenth of that of α-amylase in the
bakeries.
The detergent factory had been operating since the 1960s; new
facilities were built in the mid-1980s. Detergents for laundry and
dishwashing were produced in separate departments. At first sight,
the factory looked tidy and not dusty, a modern automated plant.
However, exposure to enzymes did take place when enzyme was
added to the hopper and during the mixing phases in the production
of dishwashing detergents. It was also reported that frequent system
failures in the process lines led to peaks of detergent dust. Granulated
proteases had been used since the 1960s, and lipase and cellulase
had been in use for 2–5 years.
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All the animal feed factories were owned by the same industrial
company. Consequently, the production methods and enzymes in use
in the respective factories were by and large identical. Powdered or
granulated enzyme premixes had been used for 7 to 9 years, but
recently the enzyme addition had been changed to a liquid form. The
manufacturing of animal feed comprised large-scale milling and
mixing of the components, followed by the pelleting and packing of
the products, in largely closed processes. Enzymes comprised only
about one millionth part of the end product. Several enzymes were
used, cellulases, hemicellulases, β-glucanases, proteases, phytases,
glucoamylases and α-amylases. Exposure to enzymes was the most
evident during the filling of the silos with enzyme premixes. In
addition, disturbances and leaks in the production lines could release
enzyme dust into the factory air.
In enzyme production, two laboratories and one enzyme
manufacturing plant were studied. In addition, the plant produced
baking yeast and the employees involved were also studied.
Altogether, the following enzymes were produced or studied:
α-amylases, glucoamylase, proteases, glucose oxidase, cellulases,
xylanases and phytase. Especially the research on cellulases and
xylanases of T.reesei origin increased markedly in the mid-1980s.
Part of the enzymes were dry dusty preparations, particularly
the cellulases. Exposure to enzymes was possible in all phases of
production, from research to fermentation, to the drying and packing
of the product. When clusters of enzyme allergies appeared in the early
1990s, industrial hygiene improvements were started in both plants.
4.2. Total dust and enzyme measurements
4.2.1. Sampling
The samples for total dust, α-amylase and protease measurement
(studies I, III and IV) were taken by a standardized method in the
breathing zone of the workers at a flow rate of 2 l/min and by
stationary sampling at a flow rate of 20 l/min, using 37–mm Millipore
AA filters for the gravimetric determination of the dust. For collecting
the cellulase and xylanase enzymes in studies I and IV, high-volume
sampling (GMW Handi-Vol 2000) at a flow rate of 25 m3/h and glass
fiber filters (Whatman GF/C) were used. The sampling times were
1–4 hours in the stationary sampling and 2–4 hours in the personal
sampling in the bakeries and the animal feed factories and 1–4 hours
and 2–4 hours, respectively, in the detergent factory.
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4.2.2. Analysis
α-Amylase was analyzed colorimetrically using a commercial standard
kit (Merckotest) (Jauhiainen et al 1993). The method gives the amount
of active enzyme. The standard curves were obtained from enzymes
identical to those used at worksites where the samples were
collected. The detection limit, which depends on sample volume,
was 0.1 µg/sample.
Protease activity was determined using the modification of the
sensitive endpoint assay for airborne proteases from Genencor
International (Geiger 1984). The standard was a Durazym®
preparation with an activity of 8.39 DPU/g (Durazym Protease Units,
Novo Nordisk A/S), and the protein content of the standard was 0.082
mg protein/mg Durazym® (Lowry method). The detection limit for
this assay was 0.25 µDPU/ml (i.e., 2.5 µDPU/filter), which equals 20
ng Durazym® protein/filter. The protease concentrations were
expressed as nanograms per cubic meter of air based on the enzyme
activity per protein content of the Durazym® standard.
Cellulase and xylanase were determined by a method based on
polyclonal antibodies, using the dot-blot technique (Hawkes et al
1982). Cellobiohydrolase I (CBH I), which accounts for 60–80% of
the cellulase complex of T.reesei (Harkki et al 1991), and xylanase
pI 9.0, one of the two major xylanases produced by T.reesei, were
determined and thus served as indicatory enzymes for the cellulase
and xylanase complexes in air. Monoclonal anti-CBH I or anti-xylanase
pI 9.0 were used. The intensity of the formed color of the sample
dots was compared with those of the standard dots. The detection
limits were 20 ng/m3 for CBH I and 2 ng/m3 for xylanase pI 9.0.
After the original studies (III–IV) some reanalysis studies were
done with the samples of the detergent and animal feed factories.
Protease was measured from the samples with an immunologic
method, using polyclonal antibodies against the commercial detergent
protease Savinase®. The protocol was a modification of that described
by Houba et al (1997), and the analysis was made by Mr Arne Ståhl
in the Sahlgrenska University Hospital, Gothenburg, Sweden.
4.3. Assessment of work-related symptoms
The participants were asked about their work history, history of
atopy, smoking habits and work-related respiratory, conjunctival and
skin symptoms indicating hypersensitivity. In studies I–III the
questionnaire was a modification of sets of questionnaires that had
been used previously in several epidemiological studies concerning
work-related allergies in Finland. In study IV the questions were taken
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from the extensive Finnish Tuohilampi-questionnaire, developed by
researchers from the FIOH, the National Public Health Institute and
several universities (Susitaival & Husman 1996). The Tuohilampi
questionnaire is based on several internationally established
questionnaires. The self-administered questionnaire was returned at
the SPT examination. The answers were checked by a physician, and
missing points were filled out and unclear answers were clarified.
4.4. Assessment of sensitization
4.4.1. Skin prick test
Sensitization was assessed by the use of SPTs. The SPTs were
performed and the results scored routinely (Kanerva et al 1991). The
test was done on the volar aspect of the forearm. The result was read
as the mean of the longest diameter of the weal and the diameter
perpendicular to it. A weal diameter of 3 mm or more and equal to
or greater than half of that formed by histamine hydrochloride (10
mg/ml) was defined as positive, indicating sensitization.
Several enzymes were tested in studies I–V. A detailed description
of the preparation of the test extract is given in publication I. In short,
dry commercial enzyme preparations were extracted in 0.1
M potassium phosphate buffer, pH 7.4, and diluted to the Coca
solution (0.5% sodium chloride, 0.3% sodium bicarbonate, 0.4%
phenol) to achieve a protein concentration of 100 µg/ml. Part of this
solution (2.5 ml) was passed through a Millex-GV filter (0.22 µm
membrane, Millipore Ltd) into a sterile vial containing 2.5 ml of
glycerol to yield a final protein concentration of 50 µg/ml (study I)
or 100 µg/ml (studies II–V). The Coca-glycerol solution served as a
negative control.
Rye, wheat, barley and oat flours were tested for the bakeries and
animal feed plants (studies I and IV). In the same workplaces, also
storage mites were tested: Acarus siro, Lepidoglyphus destruens and
Tyrophagus putrescentiae (Allergologisk Laboratorium A/S, ALK,
Copenhagen, Denmark).
Atopy was assessed by SPT with the following panel of common
environmental allergens: cat, dog, timothy, birch, alder, mugwort,
house dust mite (Dermatophagoides pteronyssinus) (ALK). A person
with one or more positive SPT reactions to environmental allergens
was defined as atopic.
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4.4.2. Immunoglobulin E measurements
Specific IgE antibodies to enzymes were determined by the
radioallergosorbent test (RAST). RAST tests were performed for the
enzyme, flour or storage mite to which the SPT was positive. Proteins
of commercial enzyme preparations were conjugated to paper discs
activated by cyanogen bromide using the method of Ceska et al
(1972). Other reagents for the RAST were obtained from Phadebas
RAST kits (Pharmacia Diagnostics, Sweden). The results, in kilounits
per liter, were based on the RAST reference serum of Pharmacia
Diagnostics. Values over 0.35 kU/l were defined as positive, indicating
sensitization.
4.5. Characterization of enzyme allergens
The antigenic characteristics of the bacterial and fungal amylases and
fungal cellulase were studied using the sodium dodecylsulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) system, according to
a modified method of Laemmli (1970), and Western blotting (Towbin
& Gordon 1984).
4.6. Lung function tests and testing bronchial
hyperreactivity (study V)
The spirograms were recorded with a Medikro 101 spirometer
(Medikro Oy, Finland). Bronchial hyperreactivity was assessed with
a histamine challenge test described by Sovijärvi et al (1993) using
an automatic dosimetric inhaler (Spira Medikro). PD15 [provocative
dose of histamine inducing a 15% drop in forced expiratory
volume in 1 s, (FEV1)] was calculated. Bronchial hyperreactivity was
confirmed if PD15 was ≤ 1.60 mg.
4.7. Specific challenge tests (study V)
Challenge tests were performed for 11 employees from the enzyme
production industry who were referred to FIOH because of suspected
occupational disease due to exposure to enzymes.
Four of them were working in the enzyme production departments
of an enzyme factory and three in the laboratory of the factory, and
four worked in a plant that spray-dried cellulase on a subcontract
basis.
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Inhalation challenges were carried out with powdered cellulase
(Econase CEP®) in a 6–m3 ventilated exposure chamber. The protein
content of the cellulase preparation was 0.77 mg/mg, out of which
70–80% was enzyme protein, according to the information provided
by the manufacturer. The cellulase was mixed with lactose powder
in varying concentrations. Four different enzyme-lactose mixtures
were used in the challenges. These amounts were derived from our
previous experiences with challenge tests using fungal α-amylase,
corresponding amounts of enzyme protein being aimed at. The
achieved air concentrations were calculated to reflect real workplace
exposures. At the lowest level, 30 mg of cellulase was mixed with
100 g of lactose, which equals 0.03% in weight. The predicted air
concentration of cellulase was calculated to be 1–5 µg/m3. At the
next consecutive levels, a tenfold increase in cellulase was used up
to 3 g of cellulase in the total amount of 100 g of a lactose-cellulase
mixture. The maximum exposure, in two cases, was 10 g of cellulase.
The mixture was placed in a bowl, and the enzyme dust was
generated with serial impacts, every 60 seconds, of pressurized air
from a nozzle over the bowl. The placebo test with lactose was
carried out with the same procedure for all patients except one, for
whom formaldehyde challenge was performed. The challenges lasted
for 30 minutes but were interrupted earlier if necessary because of
symptoms. PEFR was recorded with a Wright peak flow meter every
15 minutes during the challenge, and afterwards every 1–4 hours until
the end of 24 hours. Diurnal peal expiratory flow curves of
unexposed days were used for reference.
4.8. Statistical methods
In assessing the significance of the level of exposure, and of atopy,
to sensitization to enzymes and in assessing the significance of
enzyme sensitization to work-related symptoms, rate ratios and their
95% confidence intervals were calculated in the Results section of
this thesis and in study II (SAS Institute Inc. 1990). For testing the
trend in the prevalence of enzyme sensitization with exposure in
study II, the Cochran-Armitage trend test was used (StatXact for
Windows 1995). In study III, the associations between work category,
atopy and symptoms were examined using logistic regression models.
Odds ratios and their 95% confidence intervals were calculated.
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5. RESULTS
5.1. Enzyme and total dust measurements
(studies I, III, IV)
The results of the enzyme and total dust measurements are
summarized in Table 9.
In the bakeries, the total dust concentrations were generally less
than 5 mg/m3. The highest levels were measured during dough
making, the personal sample values of total dust being around
10 mg/m3. Local exhaust ventilation was used in one bakery, and,
accordingly, lower levels (3–5 mg/m3) of total dust were found there.
The α-amylase concentrations were also highest in dough making,
up to 6.6 µg/m3, whereas in bread making they were generally below
0.2 µg/m3. Cellulase was not detected. Xylanase concentrations of
2–200 ng/m3 (mean 65 ng/m3) were found.
In the flour mill, total dust exposure was also high, up to
6.7 mg/m3, during mixing operations. The α-amylase concentration
was up to 1.1 µg/m3, and the cellulase concentration was up to
180 ng/m3 at the site where additives were mixed.
In the rye crisp factory, the total dust concentrations were
generally less than in the bakeries and the flour mill (mean value
3.1 mg/m3 for the personal samples and 0.8 mg/m3 for the stationary
samples). The α-amylase levels were also lower, mean value being
0.1 µg/m3 for personal samples and 0.03 µg/m3 for the stationary
samples. The cellulase concentrations ranged from 25 to 160 ng/m3
in different phases of the mixing, dough making and bread forming.
At the same sites, lower levels (7–40 ng/m3) of xylanase were
measured.
Systematic measurements of the enzyme concentrations in enzyme
production and the laboratories could not be obtained at the time of
the study. Some cellulase measurements were done by the companies
themselves, air concentrations of 40–60 ng/m3 being detected during
the weighing of samples in a laminar flow cabin and in a weighing
room. There are no data from work phases in which higher exposure
to enzymes was likely earlier, such as the mixing, drying and packing
of enzymes. In comparison, measurements in another plant, where
spray drying (as in plant B) and the packing of cellulase were
performed on a subcontract basis, revealed cellulase concentrations
of 6–7 µg/m3 during packing. The highest concentrations, up to
120 µg/m3, were measured in a spray-drying hall due to obvious leaks
in the conveyor lines.
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In the detergent factory, the total dust exposure was clearly less
than in the baking industry, ranging from <0.07 to 1.3 mg/m3 in the
personal samples. The protease concentration ranged from <55 to
1300 ng/m3 in the personal samples and from <4.0 to 1500 ng/m3 in
the stationary samples. The high (1300 and 1500 ng/m3) results were
obtained in a dusty mixing site in the production of dishwashing
detergents. In the production of laundry detergents the level was
generally below 50 ng/m3.
In the animal feed factories, the total dust concentrations varied
from < 0.1 to 38 mg/m3. The protease levels followed the total dust
levels, irrespective of the use of added enzyme. Accordingly, the
highest protease concentrations, up to 2900 ng/m3 in the stationary
samples and 360 ng/m3 in the personal samples, were measured in
the grain receipt stations. In comparison, in several other locations,
the protease concentration was below the detection limits of
40 ng/m3 in the personal samples and 4 ng/m3 in the stationary
samples. Likewise, the highest α-amylase concentration (200 ng/m3)
was detected in the process areas, where also the total dust level was
high, up to 7.8 mg/m3. However, the correlation with total dust was
not uniform, and levels of 50–90 ng/m3 were found (e.g., at bagging
and enzyme doser sites) with total dust concentrations of 0.6–
11.7 mg/m3. At the premix handling site, the area samples of xylanase
gave values of 0.7–4.5 ng/m3.
For the assessment of the comparability between the protease
measurements, the samples from the detergent and animal feed
factories were analyzed with an immunologic assay, the detergent
protease Savinase® being used as the standard. In the animal feed
factories, only three samples showed Savinase levels slightly over the
detection limit (0.07 ng/m3). There was no correlation with the
protease levels obtained by the catalytic method, which showed
elevated protease concentrations in various parts of the factories. In
the detergent factory, on the other hand, the immunologic method
showed values over the detection limit of 4 ng/m3 in six samples.
The highest concentrations were 56 ng/m3 and 62 ng/m3, measured
at the mixing site in the production of dishwashing detergents. The
catalytic method showed the highest protease concentrations at the
same sites. The results of the immunologic and the catalytic methods
correlated well (correlation coefficient 0.99, p = 0.0002) (Figure 1).
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Figure 1. Correlation of the protease measurements using the catalytic
method and the immunologic method.
5.2. Sensitization to enzymes (studies I–IV)
The prevalence of sensitization to enzymes in the workplaces is
summarized in Table 10.
The prevalence of enzyme sensitization, according to the SPT, was
7.8% for all employees in the bakeries and 11.8% for the bakers’
subgroup. The rate was 5.3% (office personnel excluded) in the flour
mill, and 3% in the rye crisp factory. The prevalence was 22.5% for
the exposed employees’ group of 40 persons in the detergent factory,
and 7.1% for the process workers’ group of 140 persons in the four
animal feed factories.
In the biotechnical research laboratory 11.7% and in the
biotechnical plant 12.6% of workers were sensitized. In the category
of research, laboratory and enzyme manufacturing work, the rates
were 12.6% and 15.4%, respectively. The workers were divided into
the following three groups according to their estimated exposure to
enzymes: “often exposed” comprising workers who had commonly
handled both the dry and liquid forms of enzymes or worked
often in rooms where dry preparations were handled by others;
“occasionally exposed” comprising workers who had handled the
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liquid form of enzymes and only occasionally worked in rooms where
dry preparations were handled by others; and “rarely or not exposed”
made up of workers who did not handle enzymes themselves but
who may have worked in laboratories where the liquid form of
enzymes was handled. There was a statistically significant (p=0.003)
exposure-response linear trend, which weakened but remained
statistically significant after stratification for atopy (p=0.01).
5.3. Sensitization to flours and storage mites
The sensitization to flours was 12% in the bakeries, 6% in the flour
mill and 8% in the rye crisp factory. In the animal feed factories the
rate was 6.8%. Storage mite sensitization was more common in the
animal feed factories (16%) than in the bakeries (9–12%).
5.4. Sensitization to environmental allergens
The prevalence of atopy (Table 8), assessed by SPT, varied from
15–16% (in the bakeries and the flour mill) to 34% (in the detergent
factory). Atopy was more common among the office workers than
among the process personnel in the baking industry, whereas, in the
detergent factory and enzyme laboratories and enzyme producing
plant, atopy was as common or more common in the “process” or
exposed groups (35% and 29%) than in the “office” or “rarely or
unexposed” group (33% and 13.6%, respectively).
5.5. Relation of atopy and smoking to
sensitization to enzymes, flours and
storage mites
Atopy was significantly associated with sensitization to enzymes
in all the workplaces except the detergent factory. Atopics were
about 3–5 times more prone to sensitization than nonatopics were
(Table 11). Likewise, atopy was significantly associated with flour
and storage mite sensitization in the baking and animal feed
industries.
Smoking was not associated with sensitization to enzymes in any
of the workplaces.
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5.6. Work-related symptoms
Work-related respiratory symptoms are summarized in Table 10.
Respiratory symptoms at work were frequently reported: in the
baking industry by 9% of “office personnel” and 18% of “process
personnel”, in the detergent factory by 11% and 47%, and in the
animal feed industry by 8% and 16%, respectively. In the biotechnical
laboratories and the biotechnical plant, up to 27% of the workers in
the group of the highest exposure reported symptoms. Most of the
symptoms (>80%) were moderate rhinitic symptoms (rhinorrhea
and/or stuffy nose). Symptoms indicating origin in the lower airways
(recurrent cough, dyspnea) were reported by 5% of the bakers and
12% of the process workers in the detergent factory.
There was a significant association between sensitization to
enzymes and work-related respiratory symptoms (Table 12).
Of the 59 people sensitized to enzymes in the workplaces studied,
34 reported work-related symptoms, 23 with rhinitis, 6 with recurrent
Table 11. Association between atopy and sensitization to enzymes
(RR = rate ratio, 95% CI = 95% confidence interval)
Industry Enzyme Enzyme RR 95% CI
sensitization in sensitization in
atopic people nonatopic people
(n/N) % (n/N) %
Baking industry 9/59 15 10/259 3.9 4.0 1.7–9.3
(process workers,
n=318)
Enzyme production 10/33 30 9/81 11 2.7 1.2–6.1
and biotechnical
laboratories
(groups 1+2:
“often” +
“occasionally “
exposed, n=114)
Detergent factory 3/14 21 6/26 23 0.9 0.3–3.2
(process workers,
n=40)
Animal feed 6/33 18 4/107 3.7 4.9 1.5–16.2
factories
(process workers,
n=140)
Total 28/139 20 29/473 6.1 3.3 2.0–5.3
As sensitization to enzymes occurred almost exclusively in the “process workers’’ groups,
the calculations were made for these groups.
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Table 12. Association between sensitization to enzymes and
respiratory symptoms at work (RR = rate ratio, 95% CI = 95% confidence interval)
Industry Symptoms in Symptoms in RR 95% CI
sensitized nonsensitized
people people
(n/N) % (n/N) %
Baking industry 8/19 46 45/299 15 2.8 1.5–5.1
(process workers,
n=318)
Enzyme production 11/19 58 15/95 16 3.7 2.0–6.7
and biotechnical
laboratories
(groups 1+2:
“often”
+ “occasionally”
exposed, n=114)
Detergent factory 9/9 100 10/31 32 3.1 1.9–5.2
(process workers,
n=40)
Animal feed factories 6/10 60 24/130 18 3.3 1.7–6.1
(process workers,
n=140)
Total 34/57 60 63/555 11 5.3 3.8–7.2
As sensitization to enzymes occurred almost exclusively in the “process workers”groups,
the calculations were made for these groups.
cough, and 5 with dyspnea. Later, 18 of these 34 persons were also
examined at FIOH. Enzyme-induced asthma was verified in 4 and
rhinitis in 12 of them using specific challenge tests.
5.7. Specific challenge tests (study V)
Challenge tests with cellulase were performed on 11 patients.
Symptoms were experienced by four patients at the lowest exposure
level (30 mg of cellulase), by four patients at the second level
(300 mg of cellulase), by two patients at the third level (3 g of
cellulase) and by one patient at the fourth level (10 g of cellulase).
Eight of the patients showed PEF drops of more than 15% in the
challenge tests. Eight people reacted with rhinorrhea, two with
pharyngeal symptoms and two with skin symptoms. There was an
association with the level of sensitization, assessed by the RAST, and
with the amount of enzyme needed to elicit the symptoms in the
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challenges, three patients with high RAST values having responded
to either 30 mg or 300 mg of cellulase, while the two RAST-negative
patients responded to only 3 g or 10 g.
The monitoring of the air in the challenge chamber showed
concentrations of cellulase ranging from 1 µg/m3 to 1.3 mg/m3 during
the challenges.
5.8. Characterization of enzyme allergens
To characterize the allergens of the enzyme extracts used in the tests,
we used sera of bakers and enzyme laboratory workers sensitized
to fungal (Aspergillus) or bacterial (Bacillus) α-amylases, and
Trichoderma cellulase-positive sera, in immunoblotting. Fungal
amylase-positive IgE was shown to bind to a band of the fungal
α-amylase with an MW of 50–60 kDa, but no binding occurred to
bacterial (Bacillus) amylase. Cellulase-positive IgE bound to several
antigens with MWs of 30–90 kDa (Figures 2–4) (Nordman et al 1993,
Vanhanen et al 1994).
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Figure 2. Binding of specific IgE antibodies to fungal α-amylase in
immunoblotting. Numbers 1–9 are serums of amylase RAST-positive patients;
number 10 is a control (RAST negative) serum.
Figure 3. Binding of specific IgE antibodies to fungal cellulase in
immunoblotting. Numbers 1–9 are cellulase RAST-positive sera.
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Figure 4 b.
Figure 4 a–b. Binding of specific IgE antibodies to fungal (a) and bacterial
(b) α-amylase in immunoblotting. Numbers 1, 3 and 6 are control (RAST
negative) sera, numbers 2, 4, 5 and 8 are fungal amylase-positive sera, and
7 is a bacterial amylase-positive serum.
Figure 4 a.
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6. DISCUSSION
Large-scale use of microbial enzymes in industry started in the 1960s
in the detergent industry and led to a wide allergy problem due to
proteases in the late 1960s and early 1970s. Substantial improvements
in industrial hygiene led to a clear decrease in the occurrence
of the allergies. However, allergies were reported later for other
applications, for example, in the pharmaceutical industry in the 1980s
and, especially, in the baking industries since the mid-1980s.
Powdered enzymes have commonly been used to improve dough in
bakeries since the 1980s.
Our studies were initiated by the referral of cases of occupational
asthma, rhinitis and dermatitis due to exposure to enzymes from the
Finnish enzyme manufacturing industry in 1989–1990 (Tarvainen et
al 1991).
It was learned that enzymes were used widely in Finnish industries,
and new applications, using novel protein engineering technologies,
were being developed constantly. Powdered enzyme preparations
were in use in most bakeries, and employees were exposed to enzyme
dust also in animal feed factories and the detergent industry, as well
as in enzyme production. Consequently, these areas were chosen as
the target for investigation. The detergent factory was intented to
function primarily as a reference workplace for our studies in that
the exposure to enzymes and the prevalence of allergies were
expected to be low on the basis of the general assumption of the
safety of encapsulated enzymes and the paucity of allergy reports from
this industry since the 1970s.
6.1. Air concentration of dust and enzymes
6.1.1.Total dust
There was a great variation in the dust concentrations between the
different workplaces and between the worksites of each workplace.
In the bakeries, the total dust concentrations were generally less than
5 mg/m3, which is the Finnish occupational exposure limit (OEL).
As expected, the highest flour dust exposure was found in dough
making, up to levels of 10 mg/m3 in personal samples. Local exhaust
ventilation was used in one bakery, lowering the exposure to levels
of 3–5 mg/m3 of total dust. The bakery results were in accordance
with values published in different countries, especially during dough
making, for which dust levels well over 10 mg/m3 and even geometric
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mean values on the order of 5–6 mg/m3 are common (Tiikkainen et
al 1996). Smith and Smith (1998) stated that “it is probably reasonable
to assume that regular exposure to total inhalable dust from bread
baking ingredients might be of the order of 5 mg/m3 8 hour time-
weighed average”.
The total dust levels in the flour mill were of the same order as in
the bakeries. The highest levels, up to 6.7 mg/m3, were measured
during the mixing operations.
The exposure was lowest in the rye crisp factory, with a mean
value of 3.1 mg/m3 for the personal samples and 0.8 mg/m3 for the
stationary samples. The low levels, when compared with the levels
in the bakeries and the flour mill can be explained by the totally
different “factory-like” processes and the automated handling of the
flours.
The dust levels greatly varied also in the animal feed factories, the
concentrations ranging from < 0.1 to 38 mg/m3. There were no data
available from animal feed industry elsewhere.
In the detergent factory the total dust exposure was clearly less
than in the baking industry, ranging from <0.07 to 1.3 mg/m3 in the
personal samples. Few data on the total dust concentrations in
other detergent factories were available for comparison: levels of
0.66–22.38 mg/m3 from the late 1960s (McMurrain 1970) and 0.2–
0.3 mg/m3 from the 1970s (Juniper et al 1977).
There was a clear difference between the contents of the dusts of
the detergent factory and those of the bakeries and animal feed
factories. The dust in the detergent factory consisted mainly of
inorganic ingredients of detergents. In the baking and animal feed
industries the dust was mainly organic, originating from grains and
flours.
6.1.2. Enzymes
We used catalytic methods to detect α-amylase and protease, and an
immunologic method to measure cellulase, xylanase and protease.
In the bakeries, high α-amylase levels, up to 6.6 µg/m3, were found
in dough making, which is the dustiest job in general, and in which
enzyme containing additives are handled. In other locations levels
were generally lower, below 0.2 µg/m3. The α-amylase levels were
comparable to those reported by Jauhiainen et al (1993) in Finnish
bakeries. The analysis of α-amylase was made with the same catalytic
method. Since 1996, immunologic methods have been employed
widely for α-amylase measurements in bakeries in Europe and Canada
(Houba et al 1996, Houba et al 1997, Sander et al 1997, Burstyn et al
1998, Nieuwenhuijsen et al 1999, Elms et al 2001). Mean exposure
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levels on the order of 10–30 ng/m3 have been reported for dough
making, with single peak values of up to 200–300 ng/m3.
Xylanase concentrations of 2–200 ng/m3 (mean 65 ng/m3)
were found, although xylanase was not a component in the dough
improvers used in the bakeries. Wheat contains small amounts of
inherent xylanolytic enzymes (Poutanen 1997), and the precence of
these enzymes may explain the result. No previous reports were
found on measurements of xylanase in bakeries.
The few measurements available from the enzyme manufacturing
industry showed cellulase concentrations of 40–60 ng/m3 during the
weighing of samples in a laminar flow cabin. Descriptions of work
practices in certain tasks, such as the mixing of powdered enzyme
preparations, indicated that clearly higher enzyme levels than
60 ng/m3 occurred at these sites. The measurements in the facilities
of a subcontract plant revealed high values of 6–7 µg/m3 for cellulase
during packing, and extremely high values, up to 120 µg/m3, in a
spray-drying hall. The high exposure levels were also reflected in a
survey in the subcontract plant, where seven cases of enzyme-induced
disease, among a workforce of about 50 workers, were diagnosed
(six cases of asthma and one case of rhinitis, three also having
urticaria) (unpublished data).
In the animal feed factories, the high levels of protease (up to 360–
2900 ng/m3) and α-amylase (up to 200 ng/m3) coincided with high
total dust levels but not with the amount of added enzyme. No data
are available for comparison on enzyme air concentrations in the
animal feed industry elsewhere.
In the detergent factory, the total dust exposure was generally
lower than in the aforementioned workplaces. In the more-automated
laundry detergent production the protease levels were generally
below 50 ng/m3. The levels were surprisingly high at the mixing site
during dishwashing detergent production (above 1000 ng/m3); the
analysis with the immunologic (Savinase) method using the same
samples gave values of 56 and 62 ng/m3. The exposure at this site
had been recognized by the company, and hoods and respiratory
protection had been arranged. In comparison, high levels of protease,
from hundreds of nanograms to tens of micrograms per cubic meter,
were reported in the detergent industry abroad in the 1970s and
1980s (Weill et al 1971, McMurrain 1970, Liss et al 1984, Schweigert
et al 2000). In the 1990s, air measurements (with immunologic
methods) revealed gradually diminishing exposures, generally below
15 ng/m3. However, the long sampling time needed fails to recognize
peak concentrations exceeding the average levels, due to, for
example, systems failures. The role of peak exposures in the
inducement of sensitization is not known.
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When the α-amylase concentrations determined in the bakeries
by the catalytic assay are compared with those measured with
immunologic assays, the difference is on the order of about tenfold.
Due to totally different measuring methods and standards, the results
are not directly comparable. The difference not only reflects the
differences in the fungal amylase concentrations in the bakeries, but
it also indicates the inherent content of amylase in the flour, which
is detected by the nonspecific catalytic method but not by the
immunologic assay. In a study by Jauhiainen et al (1993), wheat flour
contained an α-amylase concentration of 1.1 mg/g, whereas two
commercial additives had an α-amylase content of 3.1 mg/g and
1.6 mg/g. Thus the amylase activity of the additives was only 1.5 to
3 times higher than that of the flour. Burdorf et al (1994), using a
catalytic method to measure amylase, showed the total amylase
content of flour dust to be 0.03% on the average. If it is assumed that
the flour dust concentration in air is 2 mg/m3, the amylase
concentration would consequently be about 0.6 µg/m3.
The parallel measurements of protease with the catalytic and the
immunologic methods in the animal feed and detergent factories
illustrated the specific and nonspecific nature of the methods. As
expected, the immunologic method, detecting only a certain detergent
protease, did not detect protease in the animal feed factories in spite
of the high protease activities shown by the catalytic method. On the
other hand, there was a correlation between the results of the two
methods in the detergent factory. In the detergent factory the origin
of the protease is the added enzymes, in contrast to the amylases and
proteases with different origins in bakeries and animal feed factories.
As the catalytic method is based on enzymatic activity only, it is
not specific as to the structure of the enzyme protein. Immunologic
methods are more specific, as they are based on polyclonal or
monoclonal antibodies towards certain purified enzyme proteins.
Methods based on monoclonal antibodies seem to be even more
specific than those based on polyclonal antibodies (Sander et al 1997,
Elms et al 2001).
In animal feed factories, the origin of the protease activity
remained unclear, but there are some possible explanations. Grain,
especially in the stage of germination, has several enzymatic activities
(Poutanen 1997). In addition, molds and mites, for example, have
been shown to contain proteases and amylases as antigenic proteins
(Robinson et al 1997, Robinson et al 1990, Lake et al 1991).
The immunologic assay for cellulase seemed to detect the added
cellulase, as the highest levels (160–180 ng/m3) were measured in
the flour mill and crisp bread factory, where cellulase was used in
additives. For comparison, there are no reported data on cellulase
measurements in bakeries, or other industries, abroad.
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The immunologic methods for enzyme detection have some
advantages over the catalytic assays. First, the immunologic methods
are specific as to the enzyme protein used in the additives, and this
specificity is necessary in controlling the health hazards in industries
using enzymes. Second, also inactive enzyme proteins (or parts of
them) are detected. Such detection is important, as it is likely that
also inactive enzyme proteins can act as allergens. One limitation of
monoclonal assays is that the production of monoclonal antibodies
is more costly and more time consuming than that of polyclonal
antibodies. In addition, as the enzyme has probably several antigens
and only one or few antigens are measured, one has to make sure
that the main allergens are detected. The more specific the assay is,
the more sensitivity is required to detect the minute amounts of the
protein. A comparison of four immunologic methods used to assess
α-amylase showed reasonably good agreement between the
three methods using polyclonal antibodies, while a method with
monoclonal antibodies showed a factor of three to six times higher
values. It remained unclear why the monoclonal method gave higher
values. A clear need for standardization was indicated (Lillienberg et
al 2000). Internationally standardized and accepted sampling and
assay methods would enable better development of the methods and
the comparability of exposure levels, as was the practice when
α-amylase was monitored in The Netherlands and the United
Kingdom (Houba et al 1997, Burstyn et al 1998, Nieuwenhuijsen et
al 1999). Standardized methods for measuring enzymes are also a
prerequisite for the setting of future exposure limits.
In the development of methods and standard assays for measuring
enzymes, difficulties arise from the fact that new enzyme profiles are
developed constantly. For example, proteases used in the detergents,
and amylases in baking, are being developed to tolerate different
pH levels and temperatures better. It follows that the more specific
a monitoring method is, the more vulnerable it will be in the future,
as the structure of the enzyme may change and thus it may be left
undetected by the antibody. Thus a more nonspecific catalytic assay,
detecting all the amylolytic, or proteolytic, activity, might be more
practicable in some instances.
6.2. Sensitization and allergy to enzymes
The prevalence of enzyme sensitization in the bakeries was 7.8%
when all the employees were taken into account and 11.8% in the
bakers’ group. The prevalence coincides with those reported
elsewhere in Europe, for example, 5–16% in the United Kingdom
(Cullinan et al 1994, Smith & Smith 1998, Jeffrey et al 1999,
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Nieuwenhuijsen et al 1999), 9% in The Netherlands (Houba et al
1996), 7.5% in Italy (DeZotti et al 1994), and 19% in Germany (Baur
1998a). The prevalence of flour sensitization in bakeries was
12%, which was on about the same order as elsewhere in Europe in
the aforementioned studies (6%–24%). The employees sensitized to
enzymes belonged to typical groups exposed to flour and enzymes,
but a detailed exposure profile was not included in the original study
design. Thus further exposure-response assessment was not possible.
It was learned that the job tasks of many of the sensitized workers
had varied over the years. The study demonstrated that exposure to
powdered additives containing enzymes leads to sensitization in
Finnish bakers. In the rye crisp factory, where exposure was less
on the whole than in the bakeries, sensitization to enzymes was
rare. Cellulase was shown to cause sensitization even at moderate
exposure levels. There was a significant association between enzyme
sensitization and work-related respiratory symptoms. However,
co-sensitization with flours was common, and the origin of the
symptoms was difficult to determine.
The animal feed industry is a new area of enzyme application. It
was demonstrated that enzymes pose an allergy risk in this industry,
too. The risk is smaller than, for example, in the baking industry, but,
still, cases of occupational asthma due to enzymes have occurred.
There was a correlation between sensitization to enzymes and work-
related symptoms, and some of the sensitized workers reported
symptoms when exposed to enzymes. One of the enzymes to which
sensitization was shown was phytase, which has been developed
solely for use in animal feeding. Previously, sensitization to phytase
was found in Finnish enzyme production (study II). These were the
first reports of allergy caused by this enzyme.
In the detergent factory, a surprisingly high prevalence (22%)
of symptomatic sensitization was found among the process workers.
In addition to established allergens in the industry, the bacterial
proteases, sensitization to new enzymes such as lipase and cellulase
was detected. This was the first publication on the allergenity of these
enzymes in the detergent industry. Sensitization to bacterial α-amylase
(Termamyl®) in the industry had been noted since the late 1980s
(Sarlo et al 1997). In a later paper from the same multinational
detergent company it was also reported that sensitization to
lipase had been detected in the early 1990s (Peters et al 2001).
In addition the present study showed that enzyme allergy is still
possible, and it can even occur at a high rate, in the detergent
industry, despite the use of encapsulated enzyme preparations that
are principally considered nondusty and safe. This conclusion
received support recently from the study of Cullinan et al (2000) in
the United Kingdom. The prevalence of sensitization and clinical
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allergy in these two studies was in clear contrast to the prevalences
reported by large multinational companies (Cathcart et al 1997,
Schweigert et al 2000, Peters et al 2001). Obviously there are large
variations in industrial hygiene conditions between different plants.
Small industries may find it economically difficult to meet all
the standards of the industrial hygiene programs conducted in
large companies, including periodic health checks and continuous
monitoring of workplace air by immunoassays (Schweigert et al 2000,
Nicholson et al 2001).
In the enzyme-producing industry, a high rate of sensitization, up
to 25%, was noted in subgroups with high levels of exposure. The
division into subgroups enabled exposure-response (sensitization and
respiratory symptoms) calculations, and a statistically significant trend
was found for both sensitization and symptoms. A unique feature was
the high allergy risk of the laboratory personnel. It turned out that
powdered enzymes had been handled rather carelessly, and, clearly,
an awareness of the sensitizing properties of the cellulolytic enzymes
was lacking.
In addition to the sensitization of the employees who handled
enzymes themselves or worked in the vicinity of enzyme handling,
some cases of sensitization were found among people not involved
directly in production, for example, among the cleaning and
maintenance personnel and also among office personnel with
occasional exposure. Maintenance workers may be exposed to the
highest peak concentrations of enzymes in the workplace. The
practice of hiring personnel on a subcontract basis is becoming
general, and this practice increases the probability of being exposed
to enzymes. The experiences gained in the subcontract plant that
spray-dried cellulase confirmed the importance of proper and
sufficient information. The employees in the subcontract plant were
clearly ignorant about the sensitizing properties of the substances
they were handling.
6.3. Role of atopy in the sensitization to
enzymes
Atopics, defined by SPT positivity to environmental allergens, were
at greater risk than nonatopics with respect to sensitization to
enzymes; the finding is in agreement with those of most reports on
high MW sensitizers. However, also nonatopics had a marked risk,
as 4–20% of the nonatopic “process workers” were sensitized.
Some data indicate that atopics are more suspectible to contract
sensitization than nonatopics especially at low exposure levels in
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bakeries (Houba et al 1996). Similar results have been reported by
Heederik et al (1999). Atopic workers had a three-fold increased
sensitization risk at low levels of rat urinary allergen exposure. The
risk increased little with increasing exposure, whereas for nonatopic
workers a steadily increasing risk was observed. On the basis of a
reanalysis of data of a previous cross-sectional study on exposure-
response relationships in bakery work, Heederik and Houba (2001)
concluded that sensitization risk is twice as high for atopics than for
nonatopics over the whole exposure range.
When the enzyme allergies emerged in the detergent industry in
the late 1960s, the practice of excluding atopics from work with
enzyme exposure was recommended (Newhouse et al 1970, Witmeur
et al 1973, Juniper et al 1977). There were, however, other opinions
stating that these measures may not be necessary when the alternative
of adequate dust suppression is effective (Weill et al 1971), and for a
long time it has been the policy of the large detergent manufacturers
not to use atopy as a selection criteria during employee recruitment
(Schweigert et al 2000, Nicholson et al 2001). This stand has also been
generally agreed upon among researchers. Atopy is common in
general population (Haahtela et al 1980). The exclusion of atopics is
not justified; although they are at greater risk, not all atopics contract
a disease, and also nonatopics become sensitized. Thus the focus
should be in decreasing exposure (Nordman 1987, Nordman 1994b,
Venables & Chan-Yeung 1997, Niven & Pickering 1999). On the other
hand, people with current asthma, chronic rhinitis or eczema of the
hands may be unsuitable for tasks with exposure to sensitizing organic
dusts, be they atopic or not (De Zotti & Bovenzi 2000).
6.4. Diagnosing enzyme-induced asthma
using specific bronchial provocation test
The challenge protocol used in this study appeared to be practical
for powdered enzymes. The workplace conditions could be mimicked
to a reasonable degree, as cellulase was commonly spray-dried and
handled as powder at the workplace. The same method has been used
for other dust provocations, such as flour and fungal α-amylase. The
protocol also enables nasal and conjunctival symptoms to be assessed,
and possibly also urticarial skin symptoms. However, the method is
not suitable for liquid enzymes. Air monitoring of the enzyme was
possible with the immonologic assay, but the method as such was
time consuming, and only a few measurements were done.
The bronchial challenge test is generally accepted as the gold
standard for diagnosing occupational asthma, especially when the
69
specific cause is searched for and when the suspected agent is new
(Nordman 1994a, Chan-Yeung & Malo 1995, Cartier 1998, Cartier
1999). We performed the tests for these reasons. However, challenge
tests for enzymes at a clinic are not always necessary (e.g., when
sensitization is proved and the symptoms are typical, and PEFR
monitoring is convincing for work-induced asthma).
6.5. Characterization of enzyme allergens
α-Amylases of different (fungal or bacterial) origin appeared to have
different antigens, shown by the immunoblotting, as antigens of
fungal α-amylase did not cross-react with antigens of bacterial
α-amylase. This finding is important with respect to diagnostics, for
example, when enzyme extracts for SPTs are chosen. It has a bearing
also on the future use of immunologic methods for measuring enzyme
concentrations in the air.
6.6. Validity issues
6.6.1. Study design and selection of study populations
All of the studies were cross-sectional, and the persons who had left
the enterprises in question were not traced. Thus the populations
were “survivors”, as those with symptomatic allergy, at least
asthmatics, had probably left the workplace. However, the
occupational health units reported that few people had left the work
due to asthma. The lower prevalence of atopy among the “process
workers” group when compared with that of the “office” group
indicates that some selection had occurred. Such selection could lead
to an underestimation of the true prevalence of symptomatic allergy.
The studies were planned in collaboration with the representatives
of the personnel and occupational health units, and this step helped
to maintain a high participation rate (>90%). Hence the population
tested formed a good representation of the workplaces studied.
6.6.2. Validity of the methods
6.6.2.1. Assessment of sensitization
SPTs were performed with a routine and well-documented method.
Enzyme test concentrations of 50 µg (protein)/ml (study I–II) or
100 µg/ml (studies III–V) were used. The shift to the stronger
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concentration was prompted by experience indicating that the milder
concentration caused rather small reactions in many workers for
whom the RAST was positive. The stronger concentration gave
clearer reactions but still reactions larger than those obtained with
histamine were uncommon. In the literature the material and
concentrations used in enzyme tests varies greatly. It is even common
that the origin and the concentrations used are left undescribed.
For fungal α-amylase, test concentrations of 1mg/ml (Baur 1998a),
5 mg/ml (Houba et al 1996), 10 mg/ml (Cullinan et al 1994,
Nieuwenhuijsen et al 1999) and 50 mg/ml (Brisman & Belin 1991)
have been reported. In comparison, the test concentration for
workers in the bakeries (study I), 50 µg protein/ml, was low, and,
accordingly, some cases of sensitization may have been missed.
However, as the origin of the extracts differed, the concentration
figures are not directly comparable. A large series of RAST tests were
also made on bakers with negative SPTs, and they too were negative.
For detergent bacterial proteases, Flindt used a concentration of
1 mg/ml (Flindt 1969); later varying concentrations between
0.01 mg/ml and 10 mg/ml have been described (Weill et al
1971, Pepys et al 1973, Belin & Norman 1977). Belin and Norman
(1977) found that test concentrations greater than 1 mg/ml caused
nonspecific irritant responses in unexposed control subjects. Their
test preparations were standardized in terms of protein concentration.
6.6.2.2. Assessment of symptoms
Two sets of self-administered questionnaires were used: one in studies
I–III and a new one in study IV. The first questionnaire was a
modification of sets of questionnaires that had been used previously
in several epidemiological studies concerning work-related allergies
in Finland; it has not been validated. The second was based on the
extensive Finnish Tuohilampi questionnaire (Susitaival & Husman
1996). The Tuohilampi questionnaire has been validated recently and
the symptom-based questions were found to have high sensitivity and
to be suitable for screening (Kilpeläinen et al 2001).
6.6.2.3. Assessment of exposure
At the time of the studies, in 1992–1997, industrial hygiene conditions
were far better in enzyme production than what they had been
earlier. In the detergent factory, a new factory building with new
facilities had been built 10 years earlier, leading probably to a
reduction in enzyme exposure. Likewise, a shift from dry enzyme
preparation to liquid enzymes was occurring in the animal feed
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industries. Consequently, the conditions seen and exposures
measured may not reflect the conditions that caused the sensitization
of workers in these industries. In the baking industry, however, the
exposure to enzymes was probably at the same level as it had been
since the start of enzyme use.
6.7. Prevention of allergies to enzymes
The high prevalences of enzyme sensitization and clinical allergy
emphasize the need for preventive measures. Indeed, the major
points of prevention were stressed already by Dr Flindt in 1969
(e.g. enclosure of processes, proper storing and cleaning methods,
and sufficient personal protective equipment).
Guidelines for the safe use of enzymes have been published, for
example, by enzyme producers (AMFEP 1994) and the detergent
industry (Gilson et al 1976, Schweigert et al 2000). In Finland, a
booklet on enzyme-containing flour additives, based partly on the
experiences and results of study I, was published by the Ministry of
Social and Health Affairs in 1997 (Aalto et al 1997).
Information is the fundamental basis of prevention. First,
employers, employees and occupational health professionals must
be aware of the properties of substances used at the workplace and
the symptoms and diseases they can cause. Material safety data sheets
should be available on substances containing enzymes, and the
sensitizing properties of the substances should be indicated in them.
Second, an industrial hygiene program to minimize exposure is
mandatory. The experience from the detergent industry and the
demonstrated exposure-response relationships prove that lowering
exposure levels is beneficial. The change from powdered proteases
to less dusty preparations proved to be beneficial in the detergent
industry. This same change could be made in the baking industry,
where the workers are clearly at risk. Paste and liquid baking additives
are already available and a major Finnish bakery company has recently
switched to using liquid enzymes in their processes. Technical
solutions to lower flour and enzyme exposure have been developed.
For example, with the introduction of local exhaust and a local
air supply at a workstation, a reduction of up to 99.8% in the dust
concentration in the breathing zone of workers was achieved
(Heinonen et al 1996, Enbom & Säämänen 1998). Personal protective
equipment can be used to supplement other measures for short
periods in the dustiest phases (e.g., during dough making). The
enclosure of processes and adequate ventilation help lower exposure.
System failures of machinery cause high peak exposures and should
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be minimized. Good work practice includes the careful handling of
enzymes. Periodic health checks at occupational health units are
widely used. The most important measure in this respect is to supply
information and to inquire about work practices and work-related
symptoms. Periodical SPTs are used in large companies as a biological
monitoring tool for controlling industrial hygiene conditions
(Schweigert et al 2000, Nicholson et al 2001). When sensitization is
detected, an analysis can be made of work practices and the
sufficiency of industrial hygiene measures. When the pitfalls and poor
availability of air monitoring methods in many industries are taken
into consideration, this method of biological monitoring is a practical
tool that can be recommended.
The detergent industry has the longest history of monitoring
enzyme concentrations in air. Air sampling can be used to determine
the general exposure conditions and to ensure the effect of industrial
hygiene improvements in the workplaces. However, due to the long
sampling time, the measurements are still not capable of showing
short duration peak exposures, which are not uncommon and may
be important in eliciting sensitization (Peters et al 2001).
Besides the threshold limit value (TLV) for subtilisin (60 ng/m3)
set by the American Conference of Governmental Industrial
Hygienists, there are no TLVs for other enzymes. The subtilisin TLV
was based on few exposure data and experience has shown that it
cannot serve as the NOAEL (no observable adverse effect level) for
proteases or other enzymes. Consequently, the detergent industry
has shifted to a guideline of 15 ng/m3 for proteases, and used an even
lower value for other enzymes (Schweigert et al 2000). According
to reports by the industry, lowering exposure to low nanogram levels
per cubic meter has almost put an end to new cases of clinical allergy
(Schweigert et al 2000). Fungal α-amylase has been shown to cause
sensitization in the low nanogram per cubic meter range (Houba et
al 1997, Nieuwenhuijsen et al 1999), in comparison with sensitization
to wheat flour in the microgram per cubic meter range (Houba et al
1998a, Houba et al 1998b). Data on animal experiments confirm the
varying potency of different enzymes to elicit sensitization. A bacterial
amylase, Termamyl®, was found to be three to ten times as potent as
a protease, subtilisin (Sarlo et al 1997a, Sarlo et al 2000). It is probable
that each enzyme is different as to its allergenic potency to humans.
Moreover, multiple exposure to enzymes may modify the response,
as indicated by animal experiments. Proteolytic enzymes in a mixture
enhanced antibody responses to other enzymes in guinea pigs (Sarlo
et al 1997b).
Setting a TLV requires that a valid method of monitoring the
substance in the workplace air be available to users. The literature
shows the need to keep at least protease and amylase levels lower
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than 60 ng/m3. Immunologic methods with very low detection limits
are available, but there is still a need for the methods to be
standardized. In addition, the constant development of new enzyme
structures by the use of protein engineering creates a need for
constant development of new antibodies and assays. Moreover, the
technical problem of monitoring short peak exposures remains. In
any case, a practical aim is the lowest possible level of enzymes in
workplace air.
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7. CONCLUSIONS
Exposure to enzyme proteins occurs in the research and production
of enzymes, and in the manufacture of detergents, bakery products
and animal feed where enzymes are used as additives or raw material.
In all the studied industries where exposure to enzymes occurred,
sensitization was demonstrated for a significant proportion of the
exposed workers. The prevalence of positive skin prick tests varied
from 3% in the rye crisp factory to 22.5% in the detergent industry.
An exposure-response relationship was established, sensitization
being more common among highly exposed workers than among
those in the lower exposure categories. The risk of sensitization to
enzymes was elevated among the atopics. However, IgE-mediated
allergy was noted also among the nonatopics.
Sensitization to enzymes increased the risk of work-related
symptoms significantly in all the studied industries. In enzyme
manufacture and biotechnical laboratories, work-related symptoms
(rhinitis, recurrent cough, dyspnea) were significantly more common
among workers exposed to enzymes than among the unexposed or
rarely exposed persons, with a linear exposure-response trend.
In addition to previously well-known enzyme allergens, such as
protease and α-amylase, the results emphasized the allergenic
properties of other enzymes, such as cellulase, phytase and lipase.
Allergy to cellulolytic enzymes was shown to be especially common
in Finland. Phytase is used in animal feed and was shown for the first
time to cause allergies.
The study showed that the structure of the enzyme protein
is determined by its origin. Thus the antigens of fungal α-amylase
did not cross-react with the antigens of bacterial α-amylase in
immunoblotting. This phenomenon is important with respect to
diagnostics and also has a bearing on the future use of immunologic
methods for measuring enzyme concentrations in the air.
Development of internationally standardized assays for measuring
air concentrations of enzymes is needed urgently. Experiences from
this study show the need to use enzyme-specific methods to
distinguish the added enzyme from the inherent ones in the product
or material in question. On the other hand, more simple and
inexpensive catalytic methods may be useful when, for example,
interfering enzyme proteins do not exist or the total amount of
detectable enzymes in air is to be determined.
Before enzyme allergy can be effectively prevented, sufficient
information about the health hazards of enzyme use must be available
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to employers, employees and occupational health personnel. Only
then can the actions needed to minimize exposure be taken, for
example, the application of local exhaust ventilation techniques and
the use of proper work practices during the handling of enzyme
products.
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